• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染后综合征患者出现神经系统症状的脑脊液检查结果。

Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome.

机构信息

Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology and Experimental Neurology, Berlin, Germany.

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

出版信息

J Neurol. 2024 Jan;271(1):59-70. doi: 10.1007/s00415-023-12092-4. Epub 2023 Nov 24.

DOI:10.1007/s00415-023-12092-4
PMID:37999770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10769962/
Abstract

BACKGROUND

Information on cerebrospinal fluid (CSF) findings in patients with neurological manifestations in post-COVID-19 syndrome is scarce.

METHODS

Retrospective evaluation of 84 CSF samples in patients fulfilling post-COVID-19 criteria in two neurological post-COVID-19 outpatient clinics.

RESULTS

In 68% of samples, all CSF parameters were normal. The most frequent pathological CSF finding was elevation of total protein (median total protein 33.3 mg/dl [total range 18.5-116.2]) in 20 of 83 (24%) samples. The second most prevalent pathological finding was a blood-CSF barrier dysfunction as measured by elevation of QAlb (median QAlb 4.65 [2.4-13.2]) in 11/84 (13%). Pleocytosis was found in only 5/84 (6%) samples and was mild in all of them. CSF-restricted oligoclonal bands were found in 5/83 (6%) samples. Anti-neuronal autoantibodies in CSF were negative in most cases, whilst 12/68 (18%) samples were positive for anti-myelin autoantibodies in serum. PCR for herpesviridae (HSV-1/-2, VZV, EBV, CMV, HHV6) showed, if at all, only weakly positive results in CSF or EDTA whole blood/plasma.

CONCLUSIONS

The majority of samples did not show any pathologies. The most frequent findings were elevation of total protein and blood-CSF barrier dysfunction with no signs of intrathecal inflammation. CSF analysis still keeps its value for exclusion of differential diagnoses.

摘要

背景

关于新冠后综合征患者出现神经表现时的脑脊液(CSF)结果信息较为匮乏。

方法

对两家新冠后神经门诊符合新冠后标准的 84 例 CSF 样本进行回顾性评估。

结果

68%的样本所有 CSF 参数均正常。最常见的异常 CSF 发现是总蛋白升高(20/83 例[24%]样本的中位数总蛋白为 33.3mg/dl[总范围 18.5-116.2])。其次常见的异常发现是血脑屏障功能障碍,白蛋白升高(11/84 例[13%]样本的中位数 QAlb 为 4.65[2.4-13.2])。仅 5/84(6%)样本发现细胞增多,且均为轻度。83 例样本中有 5 例(6%)发现 CSF 寡克隆带受限。CSF 中抗神经元自身抗体在大多数情况下为阴性,而 12/68(18%)例血清中抗髓鞘自身抗体阳性。疱疹病毒(HSV-1/-2、VZV、EBV、CMV、HHV6)的 PCR 检测结果在 CSF 或 EDTA 全血/血浆中仅呈弱阳性,若有阳性结果。

结论

大多数样本未显示任何病理学异常。最常见的发现是总蛋白升高和血脑屏障功能障碍,无鞘内炎症迹象。CSF 分析仍然具有排除鉴别诊断的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9977/10769962/fec7d8ca9469/415_2023_12092_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9977/10769962/304c0eeeaf7b/415_2023_12092_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9977/10769962/0b5b595251e7/415_2023_12092_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9977/10769962/fec7d8ca9469/415_2023_12092_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9977/10769962/304c0eeeaf7b/415_2023_12092_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9977/10769962/0b5b595251e7/415_2023_12092_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9977/10769962/fec7d8ca9469/415_2023_12092_Fig3_HTML.jpg

相似文献

1
Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome.新冠病毒感染后综合征患者出现神经系统症状的脑脊液检查结果。
J Neurol. 2024 Jan;271(1):59-70. doi: 10.1007/s00415-023-12092-4. Epub 2023 Nov 24.
2
Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.COVID-19 患者的脑脊液检查结果:127 例患者 150 次腰椎穿刺的多中心研究。
J Neuroinflammation. 2022 Jan 20;19(1):19. doi: 10.1186/s12974-021-02339-0.
3
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.患者脑脊液中髓鞘少突胶质细胞糖蛋白 (MOG) 抗体的发现。第 2 部分:80 例儿科患者 108 次腰椎穿刺的结果。
J Neuroinflammation. 2020 Sep 3;17(1):262. doi: 10.1186/s12974-020-01825-1.
4
SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study.新型冠状病毒肺炎患者脑脊液中的严重急性呼吸综合征冠状病毒2和自身抗体:前瞻性多中心队列研究
Brain Commun. 2023 Oct 17;5(5):fcad274. doi: 10.1093/braincomms/fcad274. eCollection 2023.
5
Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients.新型冠状病毒 2019 患者的脑脊液特征和神经表现:与 58 例患者脑磁共振成像结果的相关性。
J Infect Dis. 2021 Feb 24;223(4):600-609. doi: 10.1093/infdis/jiaa745.
6
Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome.脑脊液脑结合自身抗体与新冠后综合征认知障碍的关联。
Brain Behav Immun. 2023 Mar;109:139-143. doi: 10.1016/j.bbi.2023.01.006. Epub 2023 Jan 16.
7
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.患者的脑脊液发现髓鞘少突胶质细胞糖蛋白 (MOG) 抗体。第 1 部分:100 例成年患者 163 次腰椎穿刺的结果。
J Neuroinflammation. 2020 Sep 3;17(1):261. doi: 10.1186/s12974-020-01824-2.
8
Cerebrospinal fluid findings in non-infectious status epilepticus.非感染性癫痫持续状态的脑脊液检查结果
Epilepsy Res. 2018 Feb;140:61-65. doi: 10.1016/j.eplepsyres.2017.12.008. Epub 2017 Dec 13.
9
Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.与 COVID-19 相关的神经系统疾病的脑脊液检查结果及对疾病发病机制的深入了解。
Int J Infect Dis. 2021 Jan;102:155-162. doi: 10.1016/j.ijid.2020.10.044. Epub 2020 Oct 28.
10
Detection of herpesvirus genomes by polymerase chain reaction in cerebrospinal fluid and clinical findings.通过聚合酶链反应检测脑脊液中的疱疹病毒基因组及临床发现。
J Clin Virol. 2002 Jul;25 Suppl 1:S59-70. doi: 10.1016/s1386-6532(02)00035-5.

引用本文的文献

1
Clinical, thyroid metabolic, and inflammatory features in pediatric patients with post-acute COVID-19 neuropsychiatric symptoms.患有急性 COVID-19 后神经精神症状的儿科患者的临床、甲状腺代谢和炎症特征。
BMC Infect Dis. 2025 Jul 30;25(1):963. doi: 10.1186/s12879-025-11333-3.
2
RhCMV reactivation in SARS-CoV-2 infected aged rhesus macaques.严重急性呼吸综合征冠状病毒2感染的老年恒河猴中猴巨细胞病毒的重新激活
Front Immunol. 2025 Jun 24;16:1616490. doi: 10.3389/fimmu.2025.1616490. eCollection 2025.
3
Cerebrospinal Fluid Proteomic Profiling Reveals Proteins Associated with Neuroinflammatory Response in COVID-19 Patients.

本文引用的文献

1
Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome.脑脊液脑结合自身抗体与新冠后综合征认知障碍的关联。
Brain Behav Immun. 2023 Mar;109:139-143. doi: 10.1016/j.bbi.2023.01.006. Epub 2023 Jan 16.
2
Long COVID: major findings, mechanisms and recommendations.长新冠:主要发现、机制和建议。
Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.
3
The neurobiology of long COVID.长期新冠的神经生物学
脑脊液蛋白质组分析揭示了与新冠肺炎患者神经炎症反应相关的蛋白质。
ACS Omega. 2025 Jun 11;10(24):25489-25497. doi: 10.1021/acsomega.5c00707. eCollection 2025 Jun 24.
4
Neuroimmune pathophysiology of long COVID.长新冠的神经免疫病理生理学
Psychiatry Clin Neurosci. 2025 Jun 19. doi: 10.1111/pcn.13855.
5
Antibodies against SARS-CoV-2 spike protein in the cerebrospinal fluid of COVID-19 patients and vaccinated controls: a multicentre study.新型冠状病毒肺炎患者及接种疫苗对照者脑脊液中抗严重急性呼吸综合征冠状病毒2刺突蛋白抗体:一项多中心研究
J Neurol. 2024 Dec 16;272(1):60. doi: 10.1007/s00415-024-12769-4.
6
The Blood-Cerebrospinal Fluid Barrier Dysfunction in Brain Disorders and Stroke: Why, How, What For?脑疾病和中风中的血脑屏障功能障碍:为何、如何、有何用?
Neuromolecular Med. 2024 Sep 15;26(1):38. doi: 10.1007/s12017-024-08806-0.
7
Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection.人疱疹病毒再激活及其在新型冠状病毒肺炎感染后急性后遗症发病机制中的潜在作用。
Geroscience. 2025 Feb;47(1):167-187. doi: 10.1007/s11357-024-01323-9. Epub 2024 Aug 29.
Neuron. 2022 Nov 2;110(21):3484-3496. doi: 10.1016/j.neuron.2022.10.006. Epub 2022 Oct 7.
4
A clinical case definition of post-COVID-19 condition by a Delphi consensus.德尔菲共识对新冠后状况的临床病例定义。
Lancet Infect Dis. 2022 Apr;22(4):e102-e107. doi: 10.1016/S1473-3099(21)00703-9. Epub 2021 Dec 21.
5
Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection.新冠病毒感染后脑脊液分析结果不提示持续的中枢神经系统感染。
Ann Neurol. 2022 Jan;91(1):150-157. doi: 10.1002/ana.26262. Epub 2021 Nov 22.
6
A Neurological Outpatient Clinic for Patients With Post-COVID-19 Syndrome - A Report on the Clinical Presentations of the First 100 Patients.新冠后综合征患者神经科门诊——首批100例患者的临床表现报告
Front Neurol. 2021 Sep 16;12:738405. doi: 10.3389/fneur.2021.738405. eCollection 2021.
7
The blood-brain barrier in systemic infection and inflammation.全身性感染和炎症中的血脑屏障。
Cell Mol Immunol. 2021 Nov;18(11):2489-2501. doi: 10.1038/s41423-021-00757-x. Epub 2021 Sep 30.
8
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.在一个国际队列中对长期新冠进行特征描述:7个月的症状及其影响。
EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j.eclinm.2021.101019. Epub 2021 Jul 15.
9
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.236379 例 COVID-19 幸存者的 6 个月神经和精神结局:使用电子健康记录的回顾性队列研究。
Lancet Psychiatry. 2021 May;8(5):416-427. doi: 10.1016/S2215-0366(21)00084-5. Epub 2021 Apr 6.
10
Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.COVID-19 患者脑脊液中的中枢神经系统损伤生物标志物升高,并与神经系统症状和疾病严重程度相关。
Eur J Neurol. 2021 Oct;28(10):3324-3331. doi: 10.1111/ene.14703. Epub 2021 Jan 19.